Loading... Please wait...

CRISPR Therapeutics AG (CRSP) Ownership

Currency in USD Disclaimer
$53.10 -$0.8 (-1.48%)
$52.31
$53.69
$37.55
$91.1
  • RECENT QUARTER TOTAL INVESTED

    $4.32 B

      $646.97 M

  • RECENT QUARTER INSTITUTIONAL OWNERSHIP PERCENTAGE

    71.52%

      1.99%

  • TOTAL INVESTED OF LAST QUARTER

    $3.67 B
  • OWNERSHIP PERCENTAGE OF LAST QUARTER

    69.53%
*Showing results of the last quarter update as of 03/31/2024

CRISPR Therapeutics AG Major Shareholders & Ownership History


Reporting Date Major Shareholder Name Shares Held Market Value Change in Shares Ownership
04/18/2024 ARK INVESTMENT MANAGEMENT LLC 8.16 M $555.98 M   -4.44% 9.97%
05/14/2024 CAPITAL INTERNATIONAL INVESTORS 7.84 M $534.17 M   27.76% 9.58%
04/19/2024 SUMITOMO MITSUI TRUST HOLDINGS, INC. 3.27 M $222.80 M   -3.00% 4.00%
05/02/2024 NIKKO ASSET MANAGEMENT AMERICAS, INC. 3.27 M $222.70 M   -3.00% 4.00%
05/15/2024 T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 2.70 M $184.33 M   -25.11% 3.31%
05/10/2024 BLACKROCK INC. 2.55 M $173.56 M   1.19% 3.21%
05/13/2024 FMR LLC 2.24 M $152.66 M   21.73% 2.83%
05/10/2024 VANGUARD GROUP INC 1.64 M $111.56 M   2.90% 2.07%
05/15/2024 NEA MANAGEMENT COMPANY, LLC 1.59 M $180.41 M   0.00% 1.94%
05/15/2024 STATE STREET CORP 1.50 M $101.91 M   -14.73% 1.89%
05/15/2024 ECOR1 CAPITAL, LLC 1.39 M $94.69 M   100.00% 1.70%
05/15/2024 MORGAN STANLEY 1.09 M $74.02 M   162.89% 1.37%
05/13/2024 SR ONE CAPITAL MANAGEMENT, LP 1.05 M $71.50 M   100.00% 1.28%
05/14/2024 LOOMIS SAYLES & CO L P 1.03 M $69.88 M   -3.95% 1.25%
05/10/2024 DIMENSIONAL FUND ADVISORS LP 931,055 $63.46 M   19.45% 1.18%
05/13/2024 GEODE CAPITAL MANAGEMENT, LLC 909,298 $62.00 M   2.89% 1.15%
05/15/2024 BANK OF AMERICA CORP /DE/ 863,214 $58.84 M   24.89% 1.09%
05/15/2024 CITADEL ADVISORS LLC 835,100 $56.92 M   -27.41% 1.05%
05/07/2024 SUSQUEHANNA INTERNATIONAL GROUP, LLP 731,200 $49.84 M   -19.97% 0.92%
05/10/2024 CREDIT SUISSE AG/ 719,309 $49.03 M   -17.90% 0.91%
05/09/2024 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 669,192 $45.61 M   2.48% 0.84%
05/10/2024 CONTRARIUS INVESTMENT MANAGEMENT LTD 666,000 $45.40 M   264.08% 0.81%
05/15/2024 BELLEVUE GROUP AG 619,950 $42.26 M   -31.15% 0.76%
05/15/2024 PRICE T ROWE ASSOCIATES INC /MD/ 600,234 $40.91 M   -30.56% 0.76%
05/07/2024 SUSQUEHANNA INTERNATIONAL GROUP, LLP 565,500 $38.54 M   27.85% 0.71%
05/15/2024 CITADEL ADVISORS LLC 485,400 $33.08 M   -30.63% 0.61%
05/03/2024 VERSANT VENTURE MANAGEMENT, LLC 498,558 $33.98 M   0.00% 0.61%
05/14/2024 FEDERATED HERMES, INC. 447,606 $30.51 M   -11.91% 0.57%
05/15/2024 AVORO CAPITAL ADVISORS LLC 419,580 $28.60 M   100.00% 0.51%
05/10/2024 JPMORGAN CHASE & CO 392,750 $26.77 M   -15.22% 0.50%
05/01/2024 BAILLIE GIFFORD & CO 395,915 $26.99 M   -6.35% 0.48%
05/15/2024 CAPTION MANAGEMENT, LLC 385,000 $26.24 M   -33.70% 0.47%
05/13/2024 UBS GROUP AG 320,377 $21.84 M   3.05% 0.40%
05/14/2024 PICTET ASSET MANAGEMENT HOLDING SA 320,523 $22.16 M   3,595.22% 0.39%
05/15/2024 CAPTION MANAGEMENT, LLC 295,000 $20.11 M   -26.25% 0.36%
05/14/2024 PEAK6 INVESTMENTS LLC 288,100 $19.64 M   1,180.44% 0.35%
05/15/2024 SQUAREPOINT OPS LLC 274,030 $18.68 M   115.17% 0.34%
05/15/2024 BARCLAYS PLC 256,331 $17.47 M   -18.10% 0.32%
04/29/2024 CAPITAL ADVISORS INC/OK 263,986 $17.99 M   3.42% 0.32%
05/14/2024 NORTHERN TRUST CORP 243,278 $16.58 M   -2.86% 0.31%
05/15/2024 VESTMARK ADVISORY SOLUTIONS, INC. 249,544 $17.01 M   44.01% 0.31%
05/15/2024 CITADEL ADVISORS LLC 237,100 $16.16 M   -13.26% 0.30%
05/15/2024 D. E. SHAW & CO., INC. 218,500 $14.89 M   35.80% 0.28%
05/10/2024 WELLS FARGO & COMPANY/MN 216,394 $14.75 M   28.50% 0.27%
05/15/2024 INTEGRAL HEALTH ASSET MANAGEMENT, LLC 220,000 $15.00 M   100.00% 0.27%
05/14/2024 EAGLE HEALTH INVESTMENTS LP 197,000 $13.43 M   100.00% 0.24%
05/15/2024 ARMISTICE CAPITAL, LLC 192,000 $13.09 M   14.29% 0.23%
05/15/2024 CAPITAL FUND MANAGEMENT S.A. 188,500 $12.85 M   789.15% 0.23%
05/16/2024 JANE STREET GROUP, LLC 175,072 $11.93 M   -63.14% 0.22%
05/15/2024 D. E. SHAW & CO., INC. 174,295 $11.88 M   367.63% 0.22%

CRISPR Therapeutics AG institutional Ownership - Frequently Asked Questions

  • Q. Who are the largest shareholders of CRSP shares?

    A. During the previous two years, 630 institutional investors and hedge funds held shares of CRISPR Therapeutics AG. The most heavily invested institutionals were:

    ARK Investment Management LLC: 8.16 M

    Capital International Investors: 7.84 M

    Sumitomo Mitsui Trust Holdings, Inc.: 3.27 M

    Nikko Asset Management Americas, Inc.: 3.27 M

    T. Rowe Price Investment Management, Inc.: 2.7 M

    BlackRock Inc.: 2.55 M

  • Q. What percentage of CRISPR Therapeutics AG stock is owned by institutional investors?

    A. 71.52% of CRISPR Therapeutics AG stock is owned by institutional investors.

  • Q. How much institutional buying is happening at CRSP ?

    A. Institutional investors have bought a total of 68.33 M shares in the last 24 months. This purchase volume represents approximately $3.63 B in transactions.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.